FDA Warns Consumers About Potential Problems At Two Baltimore Pharmacies

Main Category: Regulatory Affairs / Drug Approvals
Also Included In: Public Health;  Pharmacy / Pharmacist
Article Date: 10 Aug 2008 - 0:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

The U.S. Food and Drug Administration is warning consumers who filled prescriptions at The Medicine Shoppe pharmacies located at 8035A Liberty Road and 5900 Reisterstown Road in Baltimore that they may have received drugs that were either expired or suspected counterfeit. The FDA is particularly concerned because a number of the drugs are for serious diseases and could have an adverse effect on treatment.

The products in question include:

-- Lisinopril (20 milligrams)
-- Guaifenesin/Dextromethorphan (600 mg and 1000 mg)
-- Gabapentin (100 mg, 300 mg and 400 mg)
-- Metoprolol (50 mg)
-- Nifedipine (30 mg)
-- Diclofenac Sodium (30 mg)
-- Glucophage (500 mg Extended Release)
-- Glucovance (125 mg and 500 mg)
-- Glipizide/Metformin (2.50 mg/250 mg)
-- Furosemide (20 mg)
-- Tamoxifen Citrate (10 mg)
-- Metformin HCl ER (500 mg)
-- Calcitrol (0.25 micrograms)

The FDA has no evidence that any other Medicine Shoppe pharmacies outside of the 8035A Liberty Road and 5900 Reisterstown Road facilities are involved.

Because the safety and efficacy of the listed drugs has not been established, the FDA is strongly advising consumers who filled prescriptions for these drugs at these two pharmacies to contact their prescribing physician immediately for new prescriptions. Additionally, consumers in possession of the above listed prescription drugs from these pharmacies should call FDA at 800-521-5783 for further information on how to dispose of the drugs.

Consumers and health care professionals can report adverse events to the FDA's MedWatch program at 800-FDA-1088, by mail at MedWatch, HF-2, FDA, 5600 Fishers Lane, Rockville, Md 20852-9787, or online at www.fda.gov/medwatch/report.htm.